North America eHealth Market will grow at a CAGR of 25.1% by 2029

North America eHealth market is driven by factors such as the increased prevalence of chronic diseases, rise in technological advancements in eHealth, increase in demand for telehealth, and increasing government initiatives supporting the use of eHealth solutions and services. Healthcare expenditure has increased across developed and emerging countries, which is expected to create a competitive advantage for manufacturers to develop new and innovative eHealth products. Additionally, the surge in healthcare expenditure and increase in the prevalence of chronic diseases positively affect the eHealth market.

However, the high treatment cost restricts patients from accommodating high-quality and practical solutions. Henceforth, the high cost of professional eHealth services has a negative impact on the cost of the overall market. Therefore, the use of telehealth affects the market's growth as patients prefer the self-monitoring of disease by telehealth devices is influencing the market.

https://www.databridgemarketresearch.com/reports/north-america-ehealth-market

A relatively new kind of healthcare delivery assisted by electronic procedures and communication is called eHealth (sometimes spelled eHealth). The word is used in various ways because it encompasses "nearly anything linked to computers and medicine," not just "Internet medicine" as it was originally defined at the time. Some contend that it can be used interchangeably with the term "health informatics," which they define as including all electronic and digital health processes. In contrast, others define it more specifically as Internet-based healthcare. It can also comprise mHealth, or m-Health, links and applications on mobile devices.

The usage of numerous digital technologies is expected in eHealth. For instance, the internet enables eHealth users to correspond via email with medical experts, access medical records, look up health information, and conduct person-to-person text, audio, and video exchanges.

Recent Development

In August 2022, Boston Scientific Corporation announced the acquisition of Obsidian, Inc., which developed the Gel Embolic Material technology and was a privately held company. In addition, the U.S. FDA has approved the GEM technology to use, and this acquisition will help Boston Scientia Corporation grow its business.

Technology

Chatbots
Artificial intelligence
Internet Of Things (IOT)
Blockchain and big data
Other

Some players in the market are Allscripts Healthcare, LLC, IBM Corporation, Athena health, Epic Systems Corporation, Koninklijke Philips N.V., Siemens Healthcare GmbH, Apple Inc., eHealth Technologies, SATmed, Teladoc Health, Inc., Doximity, Inc., Implantica, Medisafe, iHealth Labs Inc, Medtronic, Boston Scientific Corporation, General Electric Company, Cantata Health Solutions, BioTelemetry, a Philips Company, McKesson Corporation, Oracle, Cisco Systems and Optum Inc.

https://dbmrbuisness.blogspot.com/2023/06/probiotics-market-to-observe-prominent.html

https://dbmrbuisness.blogspot.com/2023/06/hip-replacement-implants-market-to.html

https://dbmrbuisness.blogspot.com/2023/06/throat-cancer-diagnostics-market-to-hit.html

https://dbmrbuisness.blogspot.com/2023/06/colorectal-cancer-diagnostics-market-to.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.